Logo image of EXPO

EXPONENT INC (EXPO) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:EXPO - US30214U1025 - Common Stock

74.58 USD
+0.23 (+0.31%)
Last: 1/16/2026, 8:10:43 PM
74.58 USD
0 (0%)
After Hours: 1/16/2026, 8:10:43 PM
Fundamental Rating

6

EXPO gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 88 industry peers in the Professional Services industry. EXPO gets an excellent profitability rating and is at the same time showing great financial health properties. EXPO does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

  • In the past year EXPO was profitable.
  • In the past year EXPO had a positive cash flow from operations.
  • EXPO had positive earnings in each of the past 5 years.
  • In the past 5 years EXPO always reported a positive cash flow from operatings.
EXPO Yearly Net Income VS EBIT VS OCF VS FCFEXPO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

1.2 Ratios

  • EXPO's Return On Assets of 13.77% is amongst the best of the industry. EXPO outperforms 90.91% of its industry peers.
  • Looking at the Return On Equity, with a value of 26.02%, EXPO is in the better half of the industry, outperforming 79.55% of the companies in the same industry.
  • With an excellent Return On Invested Capital value of 14.36%, EXPO belongs to the best of the industry, outperforming 80.68% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for EXPO is significantly above the industry average of 11.85%.
  • The 3 year average ROIC (18.56%) for EXPO is well above the current ROIC(14.36%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 13.77%
ROE 26.02%
ROIC 14.36%
ROA(3y)15.66%
ROA(5y)15.2%
ROE(3y)28.66%
ROE(5y)26.61%
ROIC(3y)18.56%
ROIC(5y)16.83%
EXPO Yearly ROA, ROE, ROICEXPO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

  • With an excellent Profit Margin value of 18.35%, EXPO belongs to the best of the industry, outperforming 86.36% of the companies in the same industry.
  • In the last couple of years the Profit Margin of EXPO has remained more or less at the same level.
  • EXPO has a better Operating Margin (20.64%) than 87.50% of its industry peers.
  • In the last couple of years the Operating Margin of EXPO has remained more or less at the same level.
  • EXPO has a better Gross Margin (92.96%) than 100.00% of its industry peers.
  • EXPO's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 20.64%
PM (TTM) 18.35%
GM 92.96%
OM growth 3Y-2.87%
OM growth 5Y0.97%
PM growth 3Y-3.48%
PM growth 5Y-0.25%
GM growth 3Y-0.15%
GM growth 5Y-0.21%
EXPO Yearly Profit, Operating, Gross MarginsEXPO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

9

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), EXPO is creating value.
  • EXPO has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, EXPO has less shares outstanding
  • There is no outstanding debt for EXPO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
EXPO Yearly Shares OutstandingEXPO Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
EXPO Yearly Total Debt VS Total AssetsEXPO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

  • EXPO has an Altman-Z score of 9.11. This indicates that EXPO is financially healthy and has little risk of bankruptcy at the moment.
  • EXPO has a better Altman-Z score (9.11) than 95.45% of its industry peers.
  • EXPO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 9.11
ROIC/WACC1.62
WACC8.88%
EXPO Yearly LT Debt VS Equity VS FCFEXPO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.3 Liquidity

  • A Current Ratio of 2.69 indicates that EXPO has no problem at all paying its short term obligations.
  • The Current ratio of EXPO (2.69) is better than 86.36% of its industry peers.
  • A Quick Ratio of 2.69 indicates that EXPO has no problem at all paying its short term obligations.
  • EXPO has a Quick ratio of 2.69. This is amongst the best in the industry. EXPO outperforms 86.36% of its industry peers.
Industry RankSector Rank
Current Ratio 2.69
Quick Ratio 2.69
EXPO Yearly Current Assets VS Current LiabilitesEXPO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

3

3. Growth

3.1 Past

  • EXPO shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -0.97%.
  • EXPO shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 6.74% yearly.
  • The Revenue has been growing slightly by 4.90% in the past year.
  • Measured over the past years, EXPO shows a small growth in Revenue. The Revenue has been growing by 6.01% on average per year.
EPS 1Y (TTM)-0.97%
EPS 3Y3.72%
EPS 5Y6.74%
EPS Q2Q%10%
Revenue 1Y (TTM)4.9%
Revenue growth 3Y6.2%
Revenue growth 5Y6.01%
Sales Q2Q%9.58%

3.2 Future

  • The Earnings Per Share is expected to grow by 5.06% on average over the next years.
  • The Revenue is expected to grow by 6.32% on average over the next years.
EPS Next Y-1.05%
EPS Next 2Y3.58%
EPS Next 3Y5.06%
EPS Next 5YN/A
Revenue Next Year4.12%
Revenue Next 2Y5.99%
Revenue Next 3Y6.32%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
EXPO Yearly Revenue VS EstimatesEXPO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
EXPO Yearly EPS VS EstimatesEXPO Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

1

4. Valuation

4.1 Price/Earnings Ratio

  • EXPO is valuated quite expensively with a Price/Earnings ratio of 36.38.
  • Based on the Price/Earnings ratio, EXPO is valued a bit more expensive than 60.23% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 27.38. EXPO is valued slightly more expensive when compared to this.
  • EXPO is valuated quite expensively with a Price/Forward Earnings ratio of 32.79.
  • Based on the Price/Forward Earnings ratio, EXPO is valued a bit more expensive than 60.23% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 24.29. EXPO is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE 36.38
Fwd PE 32.79
EXPO Price Earnings VS Forward Price EarningsEXPO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, EXPO is valued a bit more expensive than 61.36% of the companies in the same industry.
  • EXPO's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 30.27
EV/EBITDA 27.46
EXPO Per share dataEXPO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • The excellent profitability rating of EXPO may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)5.4
EPS Next 2Y3.58%
EPS Next 3Y5.06%

5

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 1.61%, EXPO has a reasonable but not impressive dividend return.
  • EXPO's Dividend Yield is a higher than the industry average which is at 1.41.
  • EXPO's Dividend Yield is comparable with the S&P500 average which is at 1.85.
Industry RankSector Rank
Dividend Yield 1.61%

5.2 History

  • EXPO has been paying a dividend for at least 10 years, so it has a reliable track record.
  • EXPO has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)N/A
Div Incr Years11
Div Non Decr Years11
EXPO Yearly Dividends per shareEXPO Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • 58.07% of the earnings are spent on dividend by EXPO. This is a bit on the high side, but may be sustainable.
DP58.07%
EPS Next 2Y3.58%
EPS Next 3Y5.06%
EXPO Yearly Income VS Free CF VS DividendEXPO Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
EXPO Dividend Payout.EXPO Dividend Payout, showing the Payout Ratio.EXPO Dividend Payout.PayoutRetained Earnings

EXPONENT INC

NASDAQ:EXPO (1/16/2026, 8:10:43 PM)

After market: 74.58 0 (0%)

74.58

+0.23 (+0.31%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)10-30
Earnings (Next)02-05
Inst Owners97.74%
Inst Owner Change0.09%
Ins Owners0.97%
Ins Owner Change0.91%
Market Cap3.72B
Revenue(TTM)571.36M
Net Income(TTM)104.84M
Analysts82.22
Price Target87.21 (16.93%)
Short Float %5.08%
Short Ratio5.9
Dividend
Industry RankSector Rank
Dividend Yield 1.61%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP58.07%
Div Incr Years11
Div Non Decr Years11
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.88%
Min EPS beat(2)3.34%
Max EPS beat(2)6.42%
EPS beat(4)4
Avg EPS beat(4)6.95%
Min EPS beat(4)3.34%
Max EPS beat(4)11.81%
EPS beat(8)7
Avg EPS beat(8)7.03%
EPS beat(12)8
Avg EPS beat(12)4.77%
EPS beat(16)12
Avg EPS beat(16)5.48%
Revenue beat(2)1
Avg Revenue beat(2)0.83%
Min Revenue beat(2)-0.43%
Max Revenue beat(2)2.1%
Revenue beat(4)3
Avg Revenue beat(4)0.77%
Min Revenue beat(4)-0.43%
Max Revenue beat(4)2.1%
Revenue beat(8)4
Avg Revenue beat(8)0.05%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.01%
PT rev (3m)-2.84%
EPS NQ rev (1m)0%
EPS NQ rev (3m)6.77%
EPS NY rev (1m)0%
EPS NY rev (3m)3.87%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.11%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)0.99%
Valuation
Industry RankSector Rank
PE 36.38
Fwd PE 32.79
P/S 6.51
P/FCF 30.27
P/OCF 28.15
P/B 9.24
P/tB 9.44
EV/EBITDA 27.46
EPS(TTM)2.05
EY2.75%
EPS(NY)2.27
Fwd EY3.05%
FCF(TTM)2.46
FCFY3.3%
OCF(TTM)2.65
OCFY3.55%
SpS11.45
BVpS8.07
TBVpS7.9
PEG (NY)N/A
PEG (5Y)5.4
Graham Number19.3
Profitability
Industry RankSector Rank
ROA 13.77%
ROE 26.02%
ROCE 19.43%
ROIC 14.36%
ROICexc 21.82%
ROICexgc 22.3%
OM 20.64%
PM (TTM) 18.35%
GM 92.96%
FCFM 21.51%
ROA(3y)15.66%
ROA(5y)15.2%
ROE(3y)28.66%
ROE(5y)26.61%
ROIC(3y)18.56%
ROIC(5y)16.83%
ROICexc(3y)30.54%
ROICexc(5y)30.82%
ROICexgc(3y)31.45%
ROICexgc(5y)31.86%
ROCE(3y)25.12%
ROCE(5y)22.78%
ROICexgc growth 3Y-10.75%
ROICexgc growth 5Y-4.18%
ROICexc growth 3Y-10.36%
ROICexc growth 5Y-3.84%
OM growth 3Y-2.87%
OM growth 5Y0.97%
PM growth 3Y-3.48%
PM growth 5Y-0.25%
GM growth 3Y-0.15%
GM growth 5Y-0.21%
F-Score6
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 92.68%
Cap/Sales 1.63%
Interest Coverage 250
Cash Conversion 103.34%
Profit Quality 117.23%
Current Ratio 2.69
Quick Ratio 2.69
Altman-Z 9.11
F-Score6
WACC8.88%
ROIC/WACC1.62
Cap/Depr(3y)141.73%
Cap/Depr(5y)120.6%
Cap/Sales(3y)2.21%
Cap/Sales(5y)1.87%
Profit Quality(3y)105.59%
Profit Quality(5y)110.44%
High Growth Momentum
Growth
EPS 1Y (TTM)-0.97%
EPS 3Y3.72%
EPS 5Y6.74%
EPS Q2Q%10%
EPS Next Y-1.05%
EPS Next 2Y3.58%
EPS Next 3Y5.06%
EPS Next 5YN/A
Revenue 1Y (TTM)4.9%
Revenue growth 3Y6.2%
Revenue growth 5Y6.01%
Sales Q2Q%9.58%
Revenue Next Year4.12%
Revenue Next 2Y5.99%
Revenue Next 3Y6.32%
Revenue Next 5YN/A
EBIT growth 1Y6.51%
EBIT growth 3Y3.15%
EBIT growth 5Y7.03%
EBIT Next Year24.48%
EBIT Next 3Y13.64%
EBIT Next 5YN/A
FCF growth 1Y55.07%
FCF growth 3Y5.33%
FCF growth 5Y10.11%
OCF growth 1Y36.83%
OCF growth 3Y5.08%
OCF growth 5Y5.99%

EXPONENT INC / EXPO FAQ

What is the fundamental rating for EXPO stock?

ChartMill assigns a fundamental rating of 6 / 10 to EXPO.


What is the valuation status of EXPONENT INC (EXPO) stock?

ChartMill assigns a valuation rating of 1 / 10 to EXPONENT INC (EXPO). This can be considered as Overvalued.


Can you provide the profitability details for EXPONENT INC?

EXPONENT INC (EXPO) has a profitability rating of 9 / 10.


What is the valuation of EXPONENT INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for EXPONENT INC (EXPO) is 36.38 and the Price/Book (PB) ratio is 9.24.


How sustainable is the dividend of EXPONENT INC (EXPO) stock?

The dividend rating of EXPONENT INC (EXPO) is 5 / 10 and the dividend payout ratio is 58.07%.